Title

Protein Kinase C Alpha Location and the Expression of Phospho-MEK and MDR1 in Hepatitis Virus-Related Hepatocellular Carcinoma Biopsies

DOI

10.4077/CJP.2010.AMK028

Authors

Chien-Chung Lin;Jin-Ming Hwang;Min-Ting Tsai;Wei-Wen Su;Li-Mien Chen;Tung-Yuan Lai;Hsi-Hsien Hsu;Shiow-Kang Yen;Chih-Yang Huang;Jer-Yuh Liu

Key Words

hepatitis C virus ; hepatocellular carcinoma ; MDR1 ; phospho-MEK ; protein kinase C alpha

PublicationName

The Chinese Journal of Physiology

Volume or Term/Year and Month of Publication

53卷2期(2010 / 04 / 01)

Page #

112 - 118

Content Language

英文

English Abstract

The purpose of this study was to elucidate the function of protein kinase C (PKC) α in human hepatocellular carcinoma (HCC). Histoimmunopathologic techniques were used to determine the localization and/or expression of PKCα, phospho-mitogen-acrivated protein kinase (MEK) and multidrug resistance 1 (MDR1) in HCC biopsies. Expression of PKCα, phospho-MEK and MDR1 was significantly increased in the region of HCC location compared with the non-tumor location. The HCC tissues were classified as cytosolic type, where PKCα was deposited in the cytoplasm in > 50% of cells, or membranous type for others. The results showed that the higher expression levels of phospho-MEK and MDR1 in HCC location were significantly associated with those patients whose cells were of the membranous type. Moreover, the expression of MDR1 in HCC location was also significantly associated with the phospho-MEK, and was significantly higher in the patients with anti-HCV negative readings. The results indicate that elevated expression of MDR1 in HCC patients with non-HCV infection may be mediated through PKC signaling pathway.

Topic Category 醫藥衛生 > 基礎醫學
Reference
  1. Tsai, J.H.,Tsai, M.T.,Su, W.W.,Chen, Y.L.,Wu, T.T.,Hsieh, Y.S.,Huang, C.Y.,Yeh, K.T.,Liu, J.Y.(2005).Expression of protein kinase C alpha in biopsies and surgical specimens of human hepatocellular carcinoma.Chinese J. Physiol.,48,139-143.
    連結:
  2. Ying, T.H.,Tsai, J.H.,Wu, T.T.,Tsai, M.T.,Su, W.W.,Hsieh, Y.S.,and Liu, J.Y.(2008).Immunochemical localization of protein kinase Cα in the biopsies of human hepatocellular carcinoma.Chinese J. Physiol.,51,269-274.
    連結:
  3. Alvaro, V.,Touraine, P.,Raisman, Vozari R.,Bai-Grenier, F.,Birman, P.,Joubert, D.(1992).Protein kinase C activity and expression in normal and adenomatous human pituitaries.Int. J. Cancer,50,724-730.
  4. Andrisani, O.M.,Barnabas, S.(1999).The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis (Review).Int. J. Oncol.,15,373-379.
  5. Baeuerle, P.A.(1998).Pro-inflammatory signaling: last pieces in the NF-κB puzzle?.Curr. Biol.,8,19-22.
  6. Borowski, P.,Schulze zur Wiesch, J.,Resch, K.,Feucht, H.,Laufs, R.,Schmitz, H.(1999).Protein kinase C recognizes the protein kinase A-binding motif of nonstructural protein 3 of hepatitis C virus.J. Biol. Chem.,274,30722-30728.
  7. Budworth, J.,Gant, T.W.,Gescher, A.(1997).Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/Adr breast carcinoma cells.Br. J. Cancer,75,1330-1335.
  8. Chang, K.J.,Lin, J.K.,Lee, P.H.,Hsieh, Y.S.,Cheng, C.K.,Liu, J.Y.(1996).The altered activity of membrane-bound protein kinase C in human liver cancer.Cancer Lett.,105,211-215.
  9. Cheng, A.L.,Chuang, S.E.,Fine, R.L.,Yeh, K.H.,Liao, C.M.,Lay, J.D.,Chen, D.S.(1998).Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicininduced apoptosis of hepatocellular carcinoma cells by tamoxifen.Biochem. Pharmacol.,55,523-531.
  10. Chenivesse, X.,Franco, D.,Brechot, C.(1993).MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis.J. Hepatol.,18,168-172.
  11. Choo, Q.L.,Richman, K.H.,Han, J.H.,Berger, K.,Lee, C.,Dong, C.,Gallegos, C.,Coit, D.,Medina-Selby, A.,Barr, P.J.,Weiner, A.J.,Bradley, D.W.,Kuo, G.,Houghton, M.(1991).Genetic organization and diversity of the hepatitis C virus.Proc. Natl. Acad. Sci. U.S.A.,88,2451-2455.
  12. CLIP Group (Cancer of the Liver Italian Programme)(1998).Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial.Lancet,352,17-20.
  13. Couldwell, W.T.,Antel, J.P.,Yong, V.W.(1992).Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C.Neurosurgery,31,717-724.
  14. Craxi, A.,Pasqua, P.,Giannuoli, G.,Di Stefano, R.,Simonetti, R.G.,Pagliaro, L.(1984).Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.Hepatogastroenterology,31,55-59.
  15. Cressman, D.E.,Greenbaum, L.E.,Haber, B.A.,Taub, R.(1994).Rapid activation of post-hepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver.J. Biol. Chem.,269,30429-30435.
  16. Di Bisceglie, A.M.(1998).Hepatitis C.Lancet,351,351-355.
  17. Doong, S.L.,Lin, M.H.,Tsai, M.M.,Li, T.R.,Chuang, S.E.,Cheng, A.L.(1998).Transactivation of the human MDR1 gene by hepatitis B virus X gene product.J. Hepatol.,29,872-878.
  18. El-Serag, H.B.(2002).Hepatocellular carcinoma: an epidemiologic view.J. Clin. Gastroenterol.,35,72-78.
  19. Farinati, F.,De Maria, N.,Marafin, C.,Herszenyi, L.,Del Prato, S.,Rinaldi, M.,Perini, L.,Cardin, R.,Naccarato, R.(1996).Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization.Dig. Dis. Sci.,41,2332-2339.
  20. Ganem, D.,Varmus, H.E.(1987).The molecular biology of the hepatitis B viruses.Annu. Rev. Biochem.,56,651-693.
  21. Gill, P.K.,Gescher, A.,Gant, T.W.(2001).Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes alpha and theta.Eur. J. Biochem.,268,4151-4157.
  22. Han, Y.,Han, Z.Y.,Zhou, X.M.,Shi, R.,Zheng, Y.,Shi ,Y.Q.,Miao, J.Y.,Pan, B.R.,Fan, D.M.(2002).Expression and function of classical protein kinase C isoenzymes in gastric cancer cell line and its drug-resistant sublines.World J. Gastroenterol.,8,441-445.
  23. Hemmings, H.C.,Adamo, A.I.(1997).Effect of halothane on conventional protein kinase C translocation and down-regulation in rat cerebrocortical synaptosomes.Br. J. Anaesth.,78,189-196.
  24. Hsieh, Y.H.,Wu, T.T.,Huang, C.Y.,Hsieh, Y.S.,Hwang, J.M.,Liu, J.Y.(2007).p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells.Cancer Res.,67,4320-4327.
  25. Hsu, S.L.,Chou, Y.H.,Yin, S.C.,Liu, J.Y.(1998).Differential effects of phorbol ester on growth and protein kinase C isoenzyme regulation in human hepatoma Hep3B cells.Biochem. J.,333,57-64.
  26. Kato, N.,Yoshida, H.,Ono-Nita, S.K.,Kato, J.,Goto, T.,Otsuka, M.,Lan, K.,Matsushima, K.,Shiratori, Y.,Omata, M.(2000).Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer.Hepatology,32,405-412.
  27. Kekule, A.S.,Lauer, U.,Weiss, L.,Luber, B.,Hofschneider, P.H.(1993).Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway.Nature,361,742-745.
  28. Kopp, R.,Noelke, B.,Sauter, G.,Schildberg, F.W.,Paumgartner, G.,Pfeiffer, A.(1991).Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas.Cancer Res.,51,205-210.
  29. Kusunoki, M.,Sakanoue, Y.,Hatada, T.,Yanagi, H.,Yamamura, T.,Utsunomiya, J.(1992).Protein kinase C activity in human colonic adenoma and colorectal carcinoma.Cancer,69,24-30.
  30. Lauer, U.,Weiss, L.,Lipp, M.,Hofschneider, P.H.,Kekule, A.S.(1994).The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation.Hepatology,19,23-31.
  31. Llovet, J.M.,Bruix, J.(2003).Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival.Hepatology,37,429-442.
  32. Luber, B.,Lauer, U.,Weiss, L.,Hohne, M.,Hofschneider, P.H.,Kekule, A.S.(1993).The hepatitis B virus transactivator HBx causes elevation of diacylglycerol and activation of protein kinase C.Res. Virol.,144,311-321.
  33. Musashi, M.,Ota, S.,Shiroshita, N.(2000).The role of protein kinase C isoforms in cell proliferation and apoptosis.Int. J. Hematol.,72,12-19.
  34. Nishizuka, Y.(1988).The molecular heterogeneity of protein kinase C and its implications for cellular regulation.Nature,334,661-665.
  35. Nishizuka, Y.(1984).The role of protein kinase C in cell surface signal transduction and tumour promotion.Nature,308,693-698.
  36. O''Brian, C.,Vogel, V.G.,Singletary, S.E.,Ward, N.E.(1989).Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue.Cancer Res.,49,3215-3217.
  37. O''Brian, C.A.,Liskamp, R.M.,Solomon, D.H.,Weinstein, I.B.(1985).Inhibition of protein kinase C by tamoxifen.Cancer Res.,45,2462-2465.
  38. Osborn, M.T.,Berry, A.,Ruberu, M.S.,Ning, B.,Bell, L.M.,Chambers, T.C.(1999).Phorbol ester induced MDR1 expression in K562 cells occurs independently of mitogen-activated protein kinase signaling pathways.Oncogene,18,5756-5764.
  39. Slater, S.J.,Cox, K.J.,Lombardi, J.V.,Ho, C.,Kelly, M.B.,Rubin, E.,Stubbs, C.D.(1993).Inhibition of protein kinase C by alcohols and anaesthetics.Nature,364,82-84.
  40. Su, Q.,Schroder, C.H.,Hofmann, W.J.,Otto, G.,Pichlmayr, R.,Bannasch, P.(1998).Expression of hepatitis B virus X protein in HBVinfected human livers and hepatocellular carcinomas.Hepatology,27,1109-1120.
  41. Tai, D.I.,Tsai, S.L.,Chen, Y.M.,Chuang, Y.L.,Peng, C.Y.,Sheen, I.S.,Yeh, C.T.,Chang, K.S.,Huang, S.N.,Kuo, G.C.,Liaw, Y.F.(2000).Activation of nuclear factor κB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis.Hepatology,31,656-664.
  42. Tsai, J.H.,Hsieh, Y.S.,Kuo, S.J.,Chen, S.T.,Yu, S.Y.,Huang, C.Y.,Chang, A.C.,Wang, Y.W.,Tsai, M.T.,Liu, J.Y.(2000).Alteration in the expression of protein kinase C isoforms in human hepatocellular carcinoma.Cancer Lett.,161,171-175.
  43. Wu, T.T.,Hsieh, Y.H.,Hsieh, Y.S.,Liu, J.Y.(2008).Reduction of PKC α decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma.J. Cell. Biochem.,103,9-20.
Times Cited
  1. 巴克斯(2018)。異甜菊醇衍生物NC-8之藥物動力學。臺北醫學大學藥學系(碩博士班)學位論文。2018。1-258。